KOL Lunch on NASH, hosted by Galmed Pharmaceuticals (GLMD)

The meeting will feature a presentation by key opinion leader (KOL) Scott Friedman, MD (Icahn School of Medicine at Mount Sinai), who will discuss the current treatment landscape and unmet medical need for patients with Non-Alcoholic Steato-hepatitis (NASH). Dr. Friedman will be available to answer questions at the conclusion of the event.